SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | n/a |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | n/a |
| Book Value / Share | n/a |
| Price / Book | n/a |
| NCAV ($M) | 0.00 |
| NCAV / Share | n/a |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | n/a |
| Current Ratio | n/a |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | n/a |
| Assets | n/a |
| Liabilities | n/a |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | n/a |
| Operating Income | n/a |
| Net Income | n/a |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | n/a |
| Cash from Investing | n/a |
| Cash from Financing | n/a |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Glazer Capital, Llc | 0.00 | ||
| 13D/A | Gamco Investors, Inc. Et Al | 0.00 | -100.00 | |
| 13D/A | Arix Bioscience plc | 1.50 | -90.00 | |
| 13G/A | Ra Capital Management, L.p. | 9.99 | 0.66 | |
| 13G/A | Citadel Advisors Llc | 6.00 | ||
| 13G/A | New Leaf Ventures III, L.P. | -9.68 | ||
| 13G | Vanguard Group Inc | 5.20 | ||
| 13D/A | MPM BioVentures 2014, L.P. | 3.70 | ||
| 13G/A | Artal International S.C.A. | 9.90 | -13.14 | |
| 13G/A | Soleus Private Equity Fund III, L.P. | 9.99 | -2.55 | |
| 13G/A | Integrated Core Strategies (us) Llc | 0.20 | ||
| 13D | Merck Sharp & Dohme Llc | 17.48 | 0.00 | |
| 13G | Cormorant Asset Management, LP | 9.90 | ||
| 13G | Commodore Capital Lp | 9.90 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Similar Companies | |
|---|---|
| AADI – Aadi Bioscience, Inc. | ABEO – Abeona Therapeutics Inc. |
| ABIO – ARCA biopharma, Inc. | ABVC – ABVC BioPharma, Inc. |
| ACB – Aurora Cannabis Inc. |
Financial data and stock pages provided by
Fintel.io